TY  - GEN
AU  - Blum,William
AU  - Garzon,Ramiro
AU  - Klisovic,Rebecca B
AU  - Schwind,Sebastian
AU  - Walker,Alison
AU  - Geyer,Susan
AU  - Liu,Shujun
AU  - Havelange,Violaine
AU  - Becker,Heiko
AU  - Schaaf,Larry
AU  - Mickle,Jon
AU  - Devine,Hollie
AU  - Kefauver,Cheryl
AU  - Devine,Steven M
AU  - Chan,Kenneth K
AU  - Heerema,Nyla A
AU  - Bloomfield,Clara D
AU  - Grever,Michael R
AU  - Byrd,John C
AU  - Villalona-Calero,Miguel
AU  - Croce,Carlo M
AU  - Marcucci,Guido
TI  - Clinical response and miR-29b predictive significance in older AML patients treated with a 10-day schedule of decitabine
SN  - 1091-6490
PY  - 2010///0527
KW  - Aged
KW  - Aged, 80 and over
KW  - Antimetabolites, Antineoplastic
KW  - therapeutic use
KW  - Azacitidine
KW  - analogs & derivatives
KW  - Cohort Studies
KW  - DNA Methylation
KW  - Decitabine
KW  - Disease-Free Survival
KW  - Female
KW  - Humans
KW  - Karyotyping
KW  - Leukemia, Myeloid, Acute
KW  - metabolism
KW  - Male
KW  - MicroRNAs
KW  - biosynthesis
KW  - Middle Aged
KW  - Remission Induction
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1073/pnas.1002650107
ER  -